Figure 1.
![Figure 1. Serial time points analysis of ROCK-1. Assessment of antibody reactivity with ROCK-1 determined by phage-plate assay in serial samples from patient 2 (early responder [ER]) and patient 4 (late responder [LR]). Quantification was based on the intensity of reactivity of the positive plaques.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/103/2/10.1182_blood-2003-07-2559/6/h80245539001.jpeg?Expires=1735523869&Signature=eK59qFhxkBqiS2j00I95jksIhBtCw0uQ0XBWMkZp9Y4IObNTu4lFSjLEKaf5aIgF1kHIunhrp8ndW0CPNZQRB9J79Gyoqi5d1vX0zS1kV1b7SNEI8U3pRLdQb~RprnozV7qyZVnszOU01GrIrSrx3fs9yX-SP13gE1HIyj8qX36ONFPmNgTvghpmKkxnkp~gFe45Mr~7lBwfE1HF5uexo9P1bl9ol4X1A9X8cPhdS~PRexVEBTVgS7eGYQlBmc-a~ZpQNWepXzMuVDTK9MS13Ww-NzG8l4lMSdJHznyiHFPMkpuDF8JOr-h78rivba4cnqm7XdRVY~gvduQmQ4gAYQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Serial time points analysis of ROCK-1. Assessment of antibody reactivity with ROCK-1 determined by phage-plate assay in serial samples from patient 2 (early responder [ER]) and patient 4 (late responder [LR]). Quantification was based on the intensity of reactivity of the positive plaques.
